NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/06/2020
Back to search
Official data from USPTO
V VBL THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/06/2020
Trademark type
Combined
Nice classes
42
Filing date
04/26/2010
Registration date
05/24/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/06/2020
Last transaction
11/06/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2009-10-00
First use in commerce
2009-10-00
Drawing code
3
Owner type
03
Owner location
Modiin, IL
Examiner
DE JONGE, KATHLEEN
Law office
L70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a blue oval with a highly stylized white offset letter "V". The black letters "VBL" appear to the right of the design with the word "THERAPEUTICS" in black located at the bottom of the mark.
Holders and representatives
Holders
Vascular Biogenics Ltd.
Vascular Biogenics Ltd.
Representatives
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals; research and development of pharmaceutical preparations and medicines; medical and scientific research services in the fields of inflammationimmuno-inflammatorychronic diseases such as rheumatoid arthritis (RA)psoriasisinflammatory bowel disease (IBD)multiple sclerosis (MS)atherosclerosiscardio vascular medicineangiogenesisvascular disruptivecancer treatment and diagnosis; medical and scientific researchconducting clinical trials; medical research; pharmaceutical drug development services; biopharmaceutical product evaluation; biopharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
32 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/06/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/06/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/06/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
09/17/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/24/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/11/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/11/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/20/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/20/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/20/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/24/2017
E815
TEAS SECTION 8 & 15 RECEIVED
02/24/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/24/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/19/2012
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/19/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2011
PUBO
PUBLISHED FOR OPPOSITION
03/08/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/01/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2011
ALIE
ASSIGNED TO LIE
01/28/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2010
GNRT
NON-FINAL ACTION E-MAILED
08/09/2010
CNRT
NON-FINAL ACTION WRITTEN
08/09/2010
DOCK
ASSIGNED TO EXAMINER
08/04/2010
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
05/01/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/30/2010
NWAP
NEW APPLICATION ENTERED
04/29/2010
Continuous trademark protection
Get notified about every new filing that threatens V VBL THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.